Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Randolph Steinhagen, MD Despite significant advances in Crohn’s disease therapy, sometimes patients have no other option but surgery. So to learn more about surgery for Crohn’s disease, Dr. Peter Buch speaks with Dr. Randolph Steinhagen, Chief of the Division of Colorectal Surgery and the Director for the Colon and Rectal Fellowship Program at Mount Sinai.

GI Insights

A Look at Crohn’s Disease from a Surgeon’s Perspective

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Camilleri, MD Many of our patients suffer from bile acid diarrhea. In fact, it’s estimated that about a third of the patients with functional diarrhea or irritable bowel syndrome with diarrhea actually have bile acid malabsorption or bile acid diarrhea, and one in every five adolescents with chronic diarrhea have evidence of bile acid diarrhea based on very simple blood tests. But despite its prevalence, bile acid diarrhea is often difficult to diagnose, which is why Dr. Peter Buch and Dr. Michael Camilleri from the Mayo Clinic come together to discuss key diagnostic and treatment strategies for bile acid diarrhea.

Breaking Down Bile Acid Diarrhea: Top Diagnostic & Treatment Strategies

Host: Neilanjan Nandi, MD Guest: Kristle Lynch, MD There are many questions and considerations that arise when managing patients with eosinophilic esophagitis, which is exactly what the 2020 AGA guidelines seek to address. Joining Dr. Neil Nandi to walk us through those guidelines and how we can apply them to the care of our patients with eosinophilic esophagitis is Dr. Kristle Lynch, Associate Professor Clinical Medicine Division of Gastroenterology and Hepatology at the Perelman School of Medicine at the University of Pennsylvania.

Applying the 2020 Eosinophilic Esophagitis Guidelines to Practice

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jeffrey Hyams, MD Many studies focus on the impact of Crohn’s disease and ulcerative colitis in adult patients, but what about our youngest patients? To learn more about how we can treat our pediatric patients with Crohn’s disease and ulcerative colitis, Dr. Peter Buch speaks with Dr. Jeffrey Hyams, one of the world’s leading experts in pediatric inflammatory bowel disease.

The Pediatric Perspective of Crohn’s Disease & Ulcerative Colitis

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hamita Sachar, MD Over the years, there has been an immense focus on defining what really constitutes a high-quality endoscopy, but many questions still remain regarding what that actually looks like in practice and how we can ensure quality in endoscopy units. That’s why Director of Ambulatory Services and Digestive Disease at Yale School of Medicine Dr. Hamita Sachar joins Dr. Peter Buch to help address some of those questions.

How Can We Ensure Quality in Endoscopy Units?

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Russell D. Cohen, MD, FACG, AGAF Are patients with inflammatory bowel disease (IBD) at increased risk for COVID-19 infection? And what should we recommend for an IBD patient in remission who tests positive for COVID-19 versus a patient with active disease? These are just some of the questions that have arisen since the onset of the COVID-19 pandemic, and the questions Dr. Peter Buch explores with Dr. Russell Cohen, Director of Inflammatory Bowel Disease Center and Co-Director of the Advanced IBD Fellowship Program at the University of Chicago School of Medicine.

Investigating the Implications of COVID-19 on IBD

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Mark Pimentel, MD Small intestinal bacterial overgrowth (SIBO) can be a challenging condition to navigate due to the several controversies surrounding its testing and treatment. Joining Dr. Peter Buch to discuss these complex issues and controversies is Dr. Mark Pimentel, Director of the Medically Associated Science and Technology Program at Cedars Sinai in Los Angeles and author of the “ACG Clinical Guideline Small Intestinal Bacterial Overgrowth” article published in the American Journal of Gastroenterology in 2020.

Navigating the Complexities of Small Intestinal Bacterial Overgrowth

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Asher A. Kornbluth, MD Since the onset of the COVID-19 pandemic, many questions have arisen regarding the care of our patients with IBD. Are they at increased risk of COVID-19? How should we treat a patient with IBD who has active COVID-19? Should they get vaccinated, and if so, when? These are all questions Dr. Peter Buch addresses with Dr. Asher Kornbluth, Clinical Professor of Medicine and Gastroenterology at Mount Sinai School of Medicine in New York, to help us optimize our approach to care amid the COVID-19 pandemic.

IBD & COVID-19: How to Manage Patients Amid the Pandemic

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Laurie Keefer, PhD While diagnosing irritable bowel syndrome and inflammatory bowel disease is critical to care, treating these illnesses and improving quality of life is just as important. Joining Dr. Peter Buch to share strategies to help counsel and care for our patients beyond diagnosis is Dr. Laurie Keefer, Professor of Medicine, Gastroenterology, and Psychiatry at Mount Sinai School of Medicine. 

Investigating IBS & IBD: An Exploration into Lifelong Management

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Cynthia L Sears, M.D. Decreased resistance to antibiotics has adversely impacted our ability to fight H. pylori. How can we help our patients overcome this threat? Dr. Peter Buch is here today to discuss this issue with Dr. Cynthia Sears, professor of medicine at the Johns Hopkins University School of Medicine to help improve health outcomes for our patients. 

Decreased Antibiotic Resistance & Overcoming the Risk of Helicobacter Pylori

GI Insights, brought to you by the American Gastroenterological Association (AGA) Institute. The American Gastroenterological Association (AGA) is dedicated to the mission of advancing the science and practice of gastroenterology.